Skip to main content
Journal of Family & Reproductive Health logoLink to Journal of Family & Reproductive Health
. 2014 Dec;8(4):135–148.

The Influence of Pregnancy and Lactation on Maternal Bone Health: A Systematic Review

Pooneh Salari 1, Mohammad Abdollahi 2,3,4
PMCID: PMC4266784  PMID: 25530765

Abstract

Osteoporosis is considered as an important public health problem especially in postmenopausal women. There are some hypotheses support the contributory effect of pregnancy and lactation on osteoporosis later in life. High calcium demand during pregnancy and lactation and low estrogenic state support those hypotheses. Numerous studies have investigated on the issue but there is no consensus about the contributory effect of pregnancy and lactation on osteoporosis. To explore the current state of fact, in the present study, all bibliographic databases were searched and all relevant studies on the topic of osteoporosis, lactation, and pregnancy were reviewed.

The review shows that despite of controversial results, pregnancy may have protective effect on bone especially if followed by lactation.

Key Words: bone loss, pregnancy, lactation, parity

Introduction

Osteoporosis is a chronic metabolic bone disease developing in both genders, but osteoporosis in postmenopausal women is of higher importance and is considered as a public health problem. Investigations try to better understand pathogenesis of osteoporosis, bone metabolism and the role of inflammatory pathways as well as the link with chronic senile diseases to find superior ways of prevention or treatment (1-5). Several contributory factors are considered essential in regulating bone metabolism as well as reaching peak bone mass in young ages (6-11). Both pregnancy and lactation are physiologic conditions mostly occurring in young women aged ≤ 40 years, in which calcium homeostasis is high. Pregnancy and lactation are proposed as two risk factors for postmenopausal osteoporosis but the studies do not support the hypothesis. Studies show 4-6% bone loss during the first six months of lactation because of hypoestrogenic state and calcium loss in breast milk (12). However there is no consensus about bone loss during lactation or the long-term effects of pregnancy and lactation on bone.

High calcium demand during pregnancy and lactation make women more prone to bone resorption and subsequent osteoporosis. Although hormonal changes cause calcium loss and result in increased bone resorption, bone resorption may be reversed after delivery (13, 14). Therefore, pregnancy and lactation can have dual effect on bone; beneficial or detrimental. The final net effect of pregnancy and lactation on bone is not obviously known and there is no consensus on the issue. In this article we reviewed and criticized the most relevant studies evaluated the impact of pregnancy and lactation on bone to provide most acceptable opinion.

Data sources

PubMed, Web of Science (ISI) and Scopus were looked for by keywords pregnancy, lactation and bone with no time limitation. We limited our search to original English papers only. All relevant papers were reviewed and data extracted.

Bone metabolism during pregnancy and lactation

Calcium homeostasis is significantly altered during pregnancy and lactation. In pregnancy 2-3% of maternal calcium is transferred to fetus mostly in the second and third trimester (15). During lactation 300-400 mg calcium per day is transferred into breast milk (16). Accordingly, many regulatory mechanisms such as renal calcium reservation, intestinal absorption, and bone resorption are stimulated (17). Because of high calcium demand during pregnancy, the rate of intestinal calcium reabsorption and bone turnover are increased (18). In the lactation period, calcium is preserved by kidneys to maintain bone metabolism (19). Despite of the involvement of several counter-regulatory pathways during pregnancy, bone mineral density decreases about 3%. The bone loss is counterbalanced by higher circulating levels of dihydroxyvitamin D, changes in parathyroid hormone (PTH), growth hormone, prolactin, estrogen, nutritional habits, body weight, and lifestyle (20,21). Little is known about the regulatory mechanism of calcium metabolism during lactation, but it is mostly mediated by PTH-related peptide (PTHrP) and hypoestrogenic state (16).

During pregnancy PTHrP is secreted from maternal and fetus tissues which increases dihydroxyvitamin D3, suppresses PTH, controls placental calcium transport and protects maternal skeleton (22).

Furthermore, during pregnancy and subsequent lactation, the ovarian activity is low (23). During lactation, increased estrogen level may equalize the imbalance between bone resorption and bone formation (24). Estrogen deficiency during postpartum amenorrhea causes bone loss and a positive association between serum estradiol and postpartum bone mineral density (BMD) was determined (25) but the importance of estrogen is not fully understood. Meanwhile menses resumption has been proposed as a major modulator of bone metabolism after pregnancy and lactation (26).

Taken together, high calcium demand and estrogen deficiency stimulate bone metabolism during pregnancy and lactation.

Pregnancy, lactation and bone

Available clinical and epidemiological data do not support permanent bone loss during pregnancy and lactation (27) and there is no consensus on the long-term effect of pregnancy and lactation on bone mass. What is the blind spot is the longitudinal effects of pregnancy and lactation on BMD and prevalence of osteoporosis. Because of a potent correlation between lactation and pregnancy, both are considered as a combined risk factor.

BMD changes in pregnancy and lactation

Pearson et al showed non-significant 1% decline in BMD at spine and hip during pregnancy and a constant pattern of bone loss during lactation especially at spine. In addition they reported restoration of 5% of the preconceptual BMD value at spine and trochanter with less recovery at total hip (28). Kolle et al observed the association of low BMD and previous pregnancy in Norwegian premenopausal women (29). In a cohort of healthy postpartum women Holmberg-Marttila et al determined systematic site specific pattern of bone loss during postpartum amenorrhea (PPA) and bone restoration after menses resumption affecting by lactation habits (30). Details of studies are summarized in Table 1.

Table 1.

Studies which show the impact of pregnancy on bone

Author Type of study Subjects Conclusion
Alderman et al. 1986 Case-control 917 PoM RF in multiparous women (≥4 birth)= RF women without birth; RF in breast-fed >2yrs= RF in women without breast feeding
Pearson et al. 2004 Longitudinal 60 PrM Constant bone loss during pregnancy; most of them returned to within 5% of normal BMD
Kolle et al. 2005 Cohort 145 (13-39 yrs) Association of low BMD and pregnancy (95%CI -0.081- -0.015, B = -0.048) (P = 0.005)
Holmberg-Marttilla et al. 2000 Cohort 41 postpartum women Systematic bone loss during PPA [at lumbar spine, mean -2.2%;95% CI, -3.4%- -0.9%; P<0.01)], [at femoral neck mean, -3.6%; 95% CI, 4.5% - -2.6%; P< 0.0001)]; BMD recovery after menses resumption [lumbar spine, mean, 3.3%; 95% CI,2.0%-- 4.6%, P < 0.0001)], [femoral neck mean, -1.0%; 95% CI,-1.7%- -0.2%; P = 0.02)]

RF = risk factor; PrM = premenopausal women; PoM = postmenopausal women; BMD = bone mineral density; yrs= years

PPA = postpartum amenorrhea; B = regression coefficient

Parity and bone

Several investigations showed long-term supportive effect of parity on bone (20,31). To & Wong observed less BMD decrement in multiparous women compared with primiparous (32).

Their results were confirmed in pre- and post-menopausal women (33,34). In contrast some researchers found high parity as a risk factor for osteoporosis (35) and indicated that having 6 children or more is associated with low spinal and hip BMD in postmenopausal women (36). Parra-Cabrera et al retrospectively assessed the effect of pregnancy on BMD in women aged (26-73 years) and reported detrimental effects of the number of pregnancies on BMD (37). Several other studies could not show the association between bone density and parity or lactation even in long term (38-41).

Some studies reported a weak to moderate protective effect of parity on risk of fracture (42, 43) while the results of the study of Parazzini et al. are against it (44). Details of the studies appeared in Table 2.

Table 2.

Studies which show the impact of parity on bone

Author Type of study Subjects Conclusion
Murphy et al. 1994 Retrospective 825 (41-76 yrs) Parity is a significant independent predictor of BMD; 1% increase in BMD per live birth
Hoffman et al. 1993 Case-control 348 (≥45 yrs) Lactation is not associated with hip fracture (OR, 0.8; 95% CI, 0.42-1.55)
Tuppurainen et al. 1995 - 1605 PrM & PoM The significant positive association between parity and BMD, Higher BMD in parrous postmenopausal women
Fox et al 1993 2230 PoM The significant positive association between parity and BMD
Berehi et al. 1996 Open study 159 Omani women (20-70 yrs) Multiparity does not influence lumbar spine BMD
Cummings et al 1995 Cohort 9516 PoM Lactation (OR, 0.9; 95% CI 0.8-1.0) is not associated with risk of hip fracture
O´Neil et al 1997 Cross sectional 7530 PoM Parity & lactation does not affect risk of vertebral deformity
Melton et al. 1993 Cross-sectional 304 PoM Pregnancy & lactation have little long term effect on bone mass
Streeten et al 2005 Observational 424 (≥40 yrs) Parity is strongly associated with BMD in women aged 50-59 yrs
Hillier et al 2003 Prospective 9704 PoM ↑Parity →↓ HF (HR, 0.87; 95% CI, 0.81-0.94)
Petersen et al 2002 Cross-sectional & prospective 5102 PoM Pregnancy is associated with low RF[number of births vs number of HF (OR, 1.22; 95% CI, 0.56-2.65)
Parazzini et al 1996 Case-control 796 PoM No influence of reproductive factors on RF[RF in parous vs nulliparous women (OR, 0.8; 95% CI, 0.6-1.3)
Demir et al. 2008 Cohort 2769 PoM High parity is a risk factor for low BMD (OR, 1.14; 95% CI, 1.08-1.21)
Allali et al 2007 Cross-sectional 730 PoM ↑ number of pregnancies →↓ hip & spine BMD; no correlation between parity and peripheral fractures
Parra-Cabrera et al. 1996 313 (26-83 yrs) Number of pregnancies → deleterious effect on BMD (r = -0.013, P = 0.007)

RF= risk factor; PrM= premenopausal women; PoM= postmenopausal women; BMD= bone mineral density; yrs= years

PPA= postpartum amenorrhea; OR= odds ratio; CI= confidence interval; HF= hip fracture; HR= hazard ratio

Lactation and bone

It was reported that bone metabolism is higher in lactating mothers with longer period of breastfeeding than that of non-lactating mothers (45). It is hypothesized that after discontinuing breast feeding, bone resorption returns to normal while bone formation continues (46). During lactation, 4-7% bone loss occurs in lumbar spine and femoral neck which is reversed about one year after weaning in a site specific manner (47, 48). Therefore bone loss during lactation seems to be partial (49) and there is the possibility of complete restoration of bone density (50,51).

Although some former studies insisted on the protective effect of lactation on BMD (52, 53), new studies indicate detrimental effects (54,55) while some others showed no significant impact (56). In addition there are some reports of negative relationship between duration of lactation and BMD (57-59) and some reports of no relationship (60). Likewise, the results of such studies in Japan, America and Sri Lanka showed opposite results (61, 62).

More et al measured BMD in pregnant women and observed that bone mass recovery continues until 12 months postpartum in women with less than one month breastfeeding. In mothers with up to 6 months breastfeeding, bone loss stops 6 months after delivery and 6 months later, it reaches baseline level. In addition, they found that if lactation continues for 12 months, bone mass does not reach baseline level (63).

Shilbayeh indicated lactation, its frequency (4 times or more) and duration (1-6 months) as significant protective elements of bone density (64). Dursun et al introduced total duration of breast feeding as an important predictor of lumbar spine BMD and observed significant lower BMD at spine and femur in Turkish women with longer duration of lactation (54). In contrast, Aksakal et al determined no significant effect of lactation on bone in pre- and post-menopausal Turkish women (65).

In a recent cohort study, Khoo et al indicated that duration of lactation is a negative predictor of BMD at hip and spine (58) which is in agreement with the study of Rojano-Mejia et al in Mexican women (59).

In a recent study, Wiklund et al displayed the protective effect of lactation on bone size and strength in direct correlation with its duration (66) while Yazici et al found no effect of lactation and its duration on postmenopausal women (67). Details of studies are summarized in Table 3.

Table 3.

Studies which show the impact of lactation on bone

Author Type of study Subjects Conclusion
Holmberg-Marttila et al. 2003 Cohort 32 healthy mothers after delivery Rate of bone formation is higher in mothers with longer period of breastfeeding
Polatti et al. 1999 Cohort 308 lactating mothers Lactation→↓BMD→recovery after weaning
Affinito et al 1996 36 (24-31 yrs) Significant decrease in BMD during lactation and partial recovery 6 months after weaning
Shilbayeh 2003 Cross-sectional 400 (19-85 yrs) Lactation, its frequency (≥4) (OR, 0.16; 95% CI, 0.03-0.84) and interval (1-6 months) are bone protective (OR, 0.07; 95% CI, 0.006-0.85)
Hansen et al. 1991 Longitudinal 121 PoM Lactation is bone protective
Feldblum et al. 1922 Cross-sectional 352 PrM Lactation has beneficial effect on BMD
Hu et al. 1994 Cross-sectional 775 (35-75 yrs) Significant positive association between lactation and BMD
Dursun et al. 2006 Cross-sectional 1486 PoM Significant negative association between total duration of lactation and BMD
Gur et al. 2003 509 PoM Extended lactation leads to lower BMD
Kalkwarf et al 1995 Cohort 113 postpartum Bone loss during lactation will be restored after weaning
Chowdhury et al. 2002 Cross-sectional 400 (20-81 yrs) Negative correlation between duration of lactation and BMD
Carranza-Lira et al. 2002 50 (35-40 yrs) Number of pregnancy and duration of lactation do not affect BMD
More et al. 2001 Prospective 38 pregnant women Significant correlation of duration of lactation with bone loss (r = -0.729)
Aksakal et al 2008 - 78 PrM & 18 PoM No significant correlation between lactation period and BMD
Chantry et al. 2004 Cross-sectional 819 (20-25 yrs) Lactation (mean, 0.049; 95% CI, 0.002-0.095) is associated with higher BMD in adolescent mothers
Khoo et al. 2011 Cohort 2000 (65-98 yrs) Lactation period is significant negative predictor of BMD (OR, -0.4; 95% CI -0.6 to -0.2)
Rojano-Mejia et al. 2011 - 567 PoM Lactation period is a risk factor for osteoporosis (OR , 2.48; 95% CI, 1.41-4.38)
Kojima et al 2002 Cross-sectional 456 PrM & 713 PoM Inverse correlation of lactation period with BMD in PrM (95% CI, -0.464- -0.098); no significant correlation in PoM
Lenora et al. 2009 Cross-sectional 210 (46-98 yrs) No detrimental effect of parity (95% CI, 6.4-7.2) and lactation (95% CI, 130.8-141.5)on BMD in PoM
Wiklund et al. 2012 Retrospective 145 (16-20 yrs) Lactation is beneficial to bone strength
Yazici et al. 2011 Retrospective 586 PoM Lactation has no effect on BMD of PoM and lactation period is not a risk factor for low BMD (OR, 0.999; 95% CI 0.993-1.005)
Berning et al 1993 Cross-sectional 94 PoM Total lactation (r = 0.29, P = 0.005) period rather than parity (r = 0.26, P = 0.01)is associated with BMD
Cure-Cure et al 2002 - 1855 PoM Osteopenia is higher in nulliparous women (OR, 2.01; 95% CI, 1.2-3.35), Parity is a protective factor against osteoporosis
Lissner et al 1991 126 Prm & PoM Higher parity & Total duration of lactation was associated with low BMC
Henderson et al. 2000 Cohort 30 grand multiparous Repeated pregnancy & lactation does not affect BMD
Grainge et al. 2001 Cross-sectional 580 PoM Number of pregnancies were strongly associated with increased BMD; no association between lactation and BMD was found
Zhang et al. 2003 Cross-sectional 214 PoM, 428 PrM More parity →negative effect on BMD, no significant impact of lactation on BMD
Paton et al. 2003 Retrospective 1935 (≥18 yrs) No long term detrimental effect of pregnancy or lactation on BMD
Hill et al. 2008 Cohort 340 PoM History of breast feeding was associated with higher BMD (OR, 1.06, 95% CI, 0.11-2.01)
Schnatz et al. 2010 Retrospective, prospective 619 (≥49 yrs) Multi parity (OR, 0.45; 95% CI, 0.22-0.95) & lactation (OR, 0.38; 95% CI, 0.2-0.72)→↓ chance of osteoporosis
Hadji et al. 2002 Cohort 2080 PoM No association between parity or lactation and ultrasonometry variables was found

RF = risk factor; PrM = premenopausal women; PoM = postmenopausal women; BMD = bone mineral density; yrs = years

PPA = postpartum amenorrhea; BMC= bone mineral content; OR = odds ratio; CI = confidence interval

Parity and lactation

The protective effects of previous lactation history and parity on bone were demonstrated in some studies (55, 68, 69) hence there is no consensus. Some former studies stated protective effect of parity and duration of lactation on BMD (70); some mentioned a negative association (71) and the others found no association (72-74). Kojima et al investigated the effect of parity and lactation on BMD in pre- and post-menopausal women in a cross-sectional study. They stated an inverse correlation between total lactation period and BMD in premenopausal women but found no association between them in the postmenopausal women and they concluded that lactation and parity does not have major effect on BMD later in life (75).

Zhang et al confirmed the detrimental effect of parity on BMD with no influence of lactation in postmenopausal Chinese women while in premenopausal women none of them caused significant association (76). Karlsson et al studied the effect of pregnancy and lactation in 73 women aged 20-44 years and observed significant decrease in spine and body BMD after delivery. In the first 12 months after delivery, the BMD of non-lactating mothers did not significantly change however 12 months after delivery, lumbar spine BMD showed significant increment (77). Meanwhile higher BMD loss was seen in lactating mothers. They could not find correlation between parity and BMD (77).

Hill et al reported the association of >5% increase in BMD of African Caribbean women with parity and lactation in age-adjusted models but the correlation was not significant (78). Lenora et al conducted a cross sectional study in Sri Lankan women and found no detrimental effect of parity and duration of lactation on BMD in postmenopausal women (62). In another former study Chantry et al indicated the positive association between lactation, age of pregnancy and bone (79).

In addition, ultrasonometry of the heel showed no significant association between ultrasonometry variables and parity or lactation in 2080 postmenopausal women (80). Details are summarized in Table 4.

Table 4.

Studies which show the impact of parity and lactation on bone

Author Type of study Subjects Conclusion
Paganini-Hill et al. 1991 Prospective 8600 PoM The negative effect of parity on RF (OR, 0.68; 95% CI, 0.48-0.9)
Kauppi et al. 2011 Prospective 2028 (≥45 yrs) ≥ 3 births →↓ RF (OR, 0.50; 95% CI, 0.32-0.79)
Taylor et al. 2004 Prospective cohort 6787 (≥66 yrs) Association of nulliparity with hip fracture (HR, 1.32; 95% CI, 1.11-1.57)
Michaelsson et al. 2001 Case-control 4640 (50-81 yrs) Parity is modestly associated with reduced hip fracture (OR, 0.95; 95% CI, 0.9-1.0)
Specker et al. 2005 Cross-sectional 168 (40-80 yrs) Association of High parity with increased bone size & strength
Huo et al. 2003 Case-control 156 (≥50 yrs) Extended duration of breast feeding (≥ 24 months) is associated with reduced hip fracture (OR, 0.31; 95% CI, 0.15-0.64)
Cumming et al. 1993 Case-control 174 (≥65 yrs) Lactation may protect against hip fracture [parous women OR, 1.53; 95% CI, 0.54-4.34)], [lactation OR, 0.64; 95% CI, 0.3-1.38)]
Boonyaratavej et al. 2001 Case-control 253(≥ 51 yrs) Lactation (OR, 0.87; 95% CI, 0.8-0.94) is a protective factor against hip fracture
Naves et al. 2005 Prospective 255 (≥50 yrs) Pregnancy is a protective factor against fracture (OR, 0.15; 95% CI, 0.03-0.62)
Mallmin et al. 1994 Case-control 367 (men & women) (40-80 yrs) Increased RF in nilliparous women (OR, 1.8; 95% CI, 1.12-2.92)

RF = risk factor; PrM = premenopausal women; PoM = postmenopausal women; BMD = bone mineral density; yrs = years

PPA = postpartum amenorrhea; BMC = bone mineral content

Pregnancy, lactation and risk of fracture

Bone loss predisposes patients to bone fractures which may cause disabilities, and work loss and imposes high cost to the society. Based on the impact of pregnancy and lactation on bone mass, different effects can be seen. Some investigations revealed reduced risk of hip fracture due to parity (31, 81, 82). Kauppi et al confirmed the positive effect of parity on BMD and showed inverse association between risk of hip fracture and parity (83). The association of nulliparity with hip fracture was confirmed in several studies (84, 85).

Michaëlsson et al. analyzed data from a population-based case-control study in Swedish women and reported 5% reduction of hip fracture per child which was influenced by use of oral contraceptives (OCP) (86). They observed that OCP increases the risk of hip fracture with no association between duration of lactation and risk of hip fracture. Also they found no correlation between body mass index (BMI), and duration of lactation with risk of fracture (86). Specker et al considered the effect of parity on bone size and strength as the factors which reduce risk of hip fracture (87).

Huo et al observed 13% reduced risk of hip fracture in association with every 6 months increase in lactation per child in Chinese women (88). In agreement with this study, Cumming et al and Kreiger et al observed the association of reduced risk of hip fracture with duration of lactation per child in a dose-dependent fashion (89, 90). In a case-control study in Thailand, addition of each child was associated with 13% reduction of risk of fracture (91) while some studies in Caucasians did not support it (31, 38, 86).

Naves et al. conducted a longitudinal study on Spanish women over 8 years and found pregnancy as an important protective factor for the incidence of Colles fractures (92). The results of the Mallmin et al study confirms this finding as they showed more Colles fractures in women who had never been pregnant (93).

Pregnancy, lactation and bone biomarkers

Because of the teratogenicity of X-ray on pregnant women, some investigators measure bone biomarkers as reliable indicators of bone status. Several studies demonstrated high maternal bone turnover specifically high levels of deoxypyridinoline (DpyD) and bone alkaline phosphatase (BALP) during pregnancy and 12 months postpartum in prospective studies (94, 95). Osteoprotegerin (OPG) which is a member of the tumor necrosis factor superfamily acts in counteraction with receptor activator of nuclear factor κB ligand (RANKL) and inhibits osteoclast activity. Production of OPG is induced by 17β-estradiol, increases over pregnancy and decreases during lactation (96, 97). It has been known that OPG is elevated in murine pregnancy which may protect maternal skeleton (98). Little is known about the role of OPG during pregnancy in human that might have placental origin. One study reported no significant change in OPG during pregnancy but increased level of OPG during labor (96)(Uemura et al., 2002). Naylor et al observed significant increase in OPG and β cross-linked C-telopeptide of type I collagen (β CTX) at 36 weeks of pregnancy followed by rapid postpartum decline (99). Their study showed no correlation between change in OPG and bone turnover or BMD (99). Vidal et al found OPG level of human milk 1000-fold higher than human serum. This high amount may prevent bone loss later in life (100).

Holmberg-Marttila et al. assessed the postpartum changes in bone turnover markers and found significant postpartum decrease in β CTX (bone resorption marker) and increase in bone alkaline phosphatase (BALP), amino-terminal telopeptide of procollagen (PINP), osteocalcin (OC) (bone formation markers) as early as one month. They indicated the association of higher parity and longer history of lactation with lower bone turnover markers (45).

Cross-sectional and longitudinal studies indicated 50% reduction of PTH during lactation (18, 49, 101-103). Also some studies reported decrease in procollagen I carboxypetides (PICP) in the first and second trimester and its increase in the last trimester as well as elevation of urine DpyD 2-3 fold during lactation higher than the third trimester (100-102, 104).

In a longitudinal study, Chan et al compared BMD and bone biomarkers of lactating and non lactating Chinese mothers and reported significant decrement in BMD of lactating mothers in the first six months as returned to baseline at 12 months. Serum BALP was higher in lactating mothers and serum intact PTH (iPTH) increased in both groups (105).

Carneiro et al reported higher levels of biochemical bone markers including CTX, N-terminal telopeptide (NTX), BALP, and osteocalcin in lactating mothers. They indicated the distinctive pattern of increased bone turnover in states of rapid bone loss (myeloma, cancer, etc) which displays uncoupling bone markers versus lactation and osteoblast-osteoclast coupling (106). Details of studies are summarized in Table 5.

Table 5.

Studies which show the impact of parity and lactation on bone biomarkers

Author Type of study Subjects Conclusion
More et al. 2003 Prospective 20 pregnant women ↑bone markers during pregnancy and lactation; fail to reach baseline 12 months postpartum
Bezerra et al. 2002 Cross-sectional 61 (14-19 yrs) & 77 (21-35 yrs) Pregnancy and lactation affect bone turnover in adolescent and adults differently
Uemura et al 2002 - 14 (23-36 yrs) Partial link between OPG and bone resorption after delivery
Naylor et al. 2003 Longitudinal 17 (20-36 yrs) No correlation between OPG change & bone turnover or BMD in pregnancy
Kovacs et al 1995 33 lactating women Lactation →↑PTHrP, Ca, P, ↓PTH
Cross et al 1995 Longitudinal 10 women ↑Bone turnover during late pregnancy & lactation
Gallacher et al. 1994 Longitudinal 10 pregnant women ↑PTHrP, BALP during pregnancy; ↑PTH postpartum
Chan et al 2005 Longitudinal 23 postpartum ↑iPTH in lactating and non lactating mothers; ↑BALP in lactating mothers
Carneiro et al. 2010 Prospective cohort 49 (24-41 yrs) ↑CTX, NTX, BALP, OC in lactating mothers than controls

RF = risk factor; PrM = premenopausal women; PoM = postmenopausal women; BMD= bone mineral density; yrs = years

OPG = osteoprotegerin; Ca = calcium; PTHrP = PTH related protein; PTH = parathormone; P = Phosphorus

CTX = cross-linked C-telopeptide of type I collagen; BBALP= bone alkaline phosphatase; NTX = cross-linked N-telopeptide of procollagen

Oc = osteocalcin; iPTH = intact parathyroid hormone

Discussion

In spite of controversial results of the mentioned studies, some investigators suggest that pregnancy causes bone loss and if pregnancy is followed by lactation, the bone density may return to normal level while the subjective reports of pregnancy-related osteoporosis and bone fractures in lactating mothers should be also taken into account (107, 108). Therefore, several contributory factors which may cause the discrepancies between results should be considered.

In order to have a more cautious and accurate conclusion, we should not ignore variations in the design of different studies (comparative groups, population characteristics, number of subjects, follow up period, and statistics), timing of the postpartum studies, nutritional status of mothers, racial differences in calcium homeostasis and bone metabolism, maternal age, parity, onset of menses, duration of lactation and bone sites which show inconsistencies of data (109-111). Some studies conducted on premenopausal women while some performed on postmenopausal women and even pregnant women; as a result the wide variations between study subjects have influenced the outcomes. Retrospective studies relied on the past memory of the subjects about lactation period, lifestyle or physical activity which might be with mistakes.

Actually, different bone sites, time and the method of bone densitometry may cause the discrepancy between results (12). Different studies show controversial results in different bone sites. Early studies showed advancing trabecular bone loss during pregnancy (112), however single and dual absorptimetry did not confirm former results (113, 114). More controversial results show increase in cortical bone density and decrease in trabecular bone density during pregnancy and postpartum (115, 116). It has been proposed that trabecular bone (lumbar spine) is more responsive to metabolic changes than the cortical bone (femoral neck, distal radius) (117). In addition, timing of bone loss in healthy women is different in bone sites. Trabecular bone mass lessens in every decade of life while cortical bone mass does not change in the third, fourth and fifth decades (118).

The method of measuring bone density or bone metabolism may be another contributory factor. Dual-energy X-ray absorptimetry (DEXA) is the most common method of measuring bone density but because of its harmful effects on fetus, alternative methods may be used during pregnancy. Accordingly fewer studies using DEXA were performed or measured bone density and its changes during pregnancy. In the recent decade, quantitative ultrasonometry (QUS) has been used for determining bone density as a safer method in pregnant women and infants. Data obtained from QUS at the heel highly correlate with its BMD and biomechanical properties; some considered this method as sensitive as axial BMD in estimating vertebral and hip fracture (119, 120). This method is inexpensive, and radiation free for measuring bone density, bone quality, and risk of fracture (121). Several investigations into the issue have been conducted by measuring bone biomarkers but bone turnover markers do not show absolute changes in bone turnover however alteration in renal function during pregnancy and lactation as well as involution of the uterus affects bone turnover markers (45). Non-fasting state, and diurnal changes seem to influence CTX levels (45). Therefore, the influence of non bone tissue and its extent should not be ignored.

Some investigators indicated the possibility of the contribution of body composition of mothers on bone mass. It has been determined that in adolescents, lean body mass and later in life, fat mass are predictors of bone mass, respectively (122). The relationship between bone loading and weight gain after delivery, increased calcium absorption during pregnancy, etc and their effects on bone mass was proposed (123) but there is no enough support for this hypothesis.

There is the possibility of age-dependent contribution. Rate of bone metabolism in adolescents is higher than adults and this may lessen their sensitivity to adoption mechanisms in pregnancy and lactation (124).

The effect of nutrition and well-defined life style should be considered. It is suggested that calcium intake can overcome the negative impact of lactation on bone mass (125 but studies show that bone loss due to lactation cannot be reversed by calcium supplementation (126); and vitamin D or PTH level is not related to bone mass change over lactation period (127). Some argue that maternal bone loss during lactation is a physiologic adaptation and cannot be prevented by calcium supplementation (128). Meanwhile, there are evidences that show decreased suckling decreases serum levels of prolactin and PTH which affects bone metabolism (127).

In contrast, maternal PTH-related peptide could provide adequate calcium for infants by stimulating bone loss (101, 125) which is reversed after weaning (129). Variations in the time since last delivery and the average duration of breastfeeding per child may affect the results as well.

There are reports which show recovery of BMD in the first 6-12 months after weaning (40). Hopkinson et al compared bone mineral content (BMC) in lactating and non lactating women during 2 years. They observed loss of 0.9% of BMC, 6 months after delivery which was recovered in 24 months whereas in non-lactating women, BMC increased 0.8% by 3 months postpartum and continued more rapidly in lactating mothers (12).

Furthermore the importance of the results should be verified according to the comprehensive definition of lactation. Based on WHO definitions there are two types of breast feeding called exclusive or predominant. Exclusive breast feeding refers to absolute breast feeding for at least 4 months and if possible 6 months even no water included and predominant breast feeding refers to the breast milk as the main source of infants nourishment but the infant may get nourished with water, or juices. These definitions were not considered in the mentioned studies. In studies using questionnaire, the researcher/researchers should trust on the subjects’ memory even after 2-3 decades.

The exact influence of hormonal status on bone during childbearing period is not fully known and its determination may be of great help. It has been suggested that during lactation, estrogen impose minor inhibitory effect on periosteal bone formation and permits periosteal expansion which increases bone size after weaning (130).

Keeping above points in mind, it seems that pregnancy itself may lead to bone loss but if followed by lactation, it will have protective effect on bone density while the duration of lactation and parity may modulate its effect. Further investigation on this topic by considering the study limitations, contributory factors and using new safe techniques such as QUS is highly recommended.

Confilict of Interests

Authors declare that they have no conflict of interest.

References

  • 1.Abdollahi M, Larijani B, Rahimi R, Salari P. Role of oxidative stress in osteoporosis. Therapy. 2005;2:787–96. [Google Scholar]
  • 2.Salari P, Abdollahi M. Controversial effects of non-steroidal anti-inflammatory drugs on bone: a review. Inflamm Allergy Drug Targets. 2009;8:169–75. doi: 10.2174/187152809788681065. [DOI] [PubMed] [Google Scholar]
  • 3.Salari P, Abdollahi M. A comprehensive review of the shared roles of inflammatory cytokines in osteoporosis and cardiovascular diseases as two common old people problem; action toward development of new drugs. Int J Pharmacol. 2011;7:552–67. [Google Scholar]
  • 4.Salari P, Larijani B, Abdollahi M. Association of hyperhomocysteinemia with osteoporosis: a systematic review. Therapy. 2008;5:215–22. [Google Scholar]
  • 5.Salari P, Rezaie A, Larijani B, Abdollahi M. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit. 2008;14:RA37–RA44. [PubMed] [Google Scholar]
  • 6.Salari P, Asalforooush M, Ameri F, Larijani B, Abdollahi M. The effects of n-fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. Age. 2010;32:179–86. doi: 10.1007/s11357-009-9122-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Salari Sharif P, Abdollahi M. A systematic review on the relationship between β-blockers and bone health. Int J Pharmacol . 2010;6:577–83. [Google Scholar]
  • 8.Salari Sharif P, Abdollahi M. The role of platelets in bone remodeling. Inflamm Allergy Drug Target . 2010;9:393–9. doi: 10.2174/187152810793938044. [DOI] [PubMed] [Google Scholar]
  • 9.Salari Sharif P, Abdollahi M. A systematic review on the relation between use of statins and osteoporosis. Int J Pharmacol. 2011;7:180–8. [Google Scholar]
  • 10.Salari Sharif P, Abdollahi M, Larijani B. Current new and future treatments of osteoporosis. Rheumatol Int . 2011;31:289–300. doi: 10.1007/s00296-010-1586-z. [DOI] [PubMed] [Google Scholar]
  • 11.Salari P, Abdollahi M. Long term bisphosphonate use in osteoporotic patients: a step forward, two steps back. J Pharm Pharmaceut Sci. 2012;15:305–17. doi: 10.18433/j3rk5j. [DOI] [PubMed] [Google Scholar]
  • 12.Hopkinson JM, Butte NF, Ellis K, Smith O. Lactation delays postpartum bone mineral accretion and temporarily alters its regional distribution in women. J Nutr. 2000;130:777–83. doi: 10.1093/jn/130.4.777. [DOI] [PubMed] [Google Scholar]
  • 13.Siva S, Roach V. Transient osteoporosis of the hip in pregnancy. Aust N Z J Obstet Gynecol. 1997;37:261–6. doi: 10.1111/j.1479-828x.1997.tb02405.x. [DOI] [PubMed] [Google Scholar]
  • 14.Rillo OL, Di Stefano CA, Bermudez J, COCCO JAM. Idiopathic osteoporosis during pregnancy. Clin Rheumatol. 1994;13:299–304. doi: 10.1007/BF02249031. [DOI] [PubMed] [Google Scholar]
  • 15.Pitkin RM. Calcium metabolism in pregnancy and the perinatal period: a review. Am J Obstet GYnecol. 1985;151:99–109. doi: 10.1016/0002-9378(85)90434-x. [DOI] [PubMed] [Google Scholar]
  • 16.Kovacs CS. Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab. 2001;86:2344–8. doi: 10.1210/jcem.86.6.7575. [DOI] [PubMed] [Google Scholar]
  • 17.O´Brien KO, Nathanson MS, Mancini J, Witter FR. Calcium absorption is significantly higher in adolescents during pregnancy than in the early postpartum period. Am J Clin Nutr. 2003;78:1188–93. doi: 10.1093/ajcn/78.6.1188. [DOI] [PubMed] [Google Scholar]
  • 18.Krebs NF, Reidinger CJ, Robertson AD, Brenner M. Bone mineral density changes during lactation: maternal, dietary, and biochemical correlates. Am J Clin Nutr. 1997;65:1738–46. doi: 10.1093/ajcn/65.6.1738. [DOI] [PubMed] [Google Scholar]
  • 19.Kalkwarf HJ. Hormonal and dietary regulation of changes in bone density during lactation and after weaning in women. J Mammary Gland Biol Neoplasia. 1999;4:319–29. doi: 10.1023/a:1018780425600. [DOI] [PubMed] [Google Scholar]
  • 20.Murphy S, Khaw KT, May H, et al. Parity and bone mineral density in middle-aged women. Osteoporos Int. 1994;4:162–6. doi: 10.1007/BF01623063. [DOI] [PubMed] [Google Scholar]
  • 21.Karlsson C, Obrant KJ, Karlsson M. Pregnancy and lactation confer reversible bone loss in humans. Osteoporos Int. 2001;12:828–34. doi: 10.1007/s001980170033. [DOI] [PubMed] [Google Scholar]
  • 22.Kovacs CS. Calcium and bone metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia. 2005;10:105–18. doi: 10.1007/s10911-005-5394-0. [DOI] [PubMed] [Google Scholar]
  • 23.Sowers M. Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res. 1996;11:1052–60. doi: 10.1002/jbmr.5650110803. [DOI] [PubMed] [Google Scholar]
  • 24.Dobnig H, Kainer F, Stepan V, Winter R, Lipp R, Schaffer M, Kahr A, Nocnik S, Patterer G, Leb G. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab. 1995;80:3699–707. doi: 10.1210/jcem.80.12.8530622. [DOI] [PubMed] [Google Scholar]
  • 25.Miller KK, Klibanski A. Clinical review 106. Amenorrheic bone loss. J Clin Endocrinol Metab. 1999;84:1775–83. doi: 10.1210/jcem.84.6.5688. [DOI] [PubMed] [Google Scholar]
  • 26.Kolthoff N, Eiken P, Kristensen B, Nielsen SP. Bone mineral changes during pregnancy and lactation: a longitudinal cohort study. Clin Sci. 1998;94:405–12. doi: 10.1042/cs0940405. [DOI] [PubMed] [Google Scholar]
  • 27.Alderman BW, Weiss NS, Daling JR, Ure CL, Ballard JH. Reproductive history and postmenopausal risk of hip and forearm fracture. Am J Epidemiol. 1986;124:262–7. doi: 10.1093/oxfordjournals.aje.a114384. [DOI] [PubMed] [Google Scholar]
  • 28.Pearson D, Kaur M, San P, Lawson N, Baker P, Hosking D. Recovery of pregnancy mediated bone loss during lactation. Bone. 2004;34:570–8. doi: 10.1016/j.bone.2003.11.005. [DOI] [PubMed] [Google Scholar]
  • 29.Kolle E, Torstveit MK, Sundgot-Borgen J. Bone mineral density in Norwegian premenopausal women. Osteoporos Int. 2005;16:914–20. doi: 10.1007/s00198-004-1783-2. [DOI] [PubMed] [Google Scholar]
  • 30.Holmberg-Marttila D, Sievänen H, Laippala P, Tuimala R. Factors underlying changes in bone mineral during postpartum amenorrhea and lactation. Osteoporos Int. 2000;11:570–6. doi: 10.1007/s001980070077. [DOI] [PubMed] [Google Scholar]
  • 31.Hoffman S, Grisso JA, Kelsey JL, Gammon MD, O'Brien LA. Parity lactation and hip fracture. Osteoporosis Int. 1993;3:171–6. doi: 10.1007/BF01623672. [DOI] [PubMed] [Google Scholar]
  • 32.To WWK, Wong MWN. Changes in bone mineral density of the os calcis measured by quantitative ultrasound during pregnancy and 24 months after delivery. Aust N Z J Obstet Gynecol. 2011;51:166–71. doi: 10.1111/j.1479-828X.2010.01266.x. [DOI] [PubMed] [Google Scholar]
  • 33.Tuppurainen M, Kroger H, Saarikoski S, Hondanen R, Alhava E. The effect of gynecological risk factors on lumbar and femoral bone mineral density in peri and postmenopausal women. Maturitas. 1995;21:137–45. doi: 10.1016/0378-5122(94)00878-b. [DOI] [PubMed] [Google Scholar]
  • 34.Fox K, Magaziner J, Sherwin R, et al. Reproductive correlates of bone mass in elderly women. J Bone Miner Res. 1993;8:901–8. doi: 10.1002/jbmr.5650080802. [DOI] [PubMed] [Google Scholar]
  • 35.Demir B, Haberal A, Geyik P, Baskan B, Ozturkoglu E, Karacay O, Deveci S. Identification of the risk factors for osteoporosis among postmenopausal women. Maturitas. 2008;60:253–6. doi: 10.1016/j.maturitas.2008.07.011. [DOI] [PubMed] [Google Scholar]
  • 36.Allali F, El Aichaoui S, Khazani H, Benyahia B, Saoud B, El Kabbaj S, Bahiri R. Influence of parity on bone mineral density and peripheral fracture risk in Moroccan postmenopausal women. Maturitas. 2007;57:392–8. doi: 10.1016/j.maturitas.2007.04.006. [DOI] [PubMed] [Google Scholar]
  • 37.Parra-Cabrera S, Hernandez-Avila M, Tamaya-y-Orozco J, Lopez-Carrillo L, Meneses-Gonzlez F. Exercise and reproductive factors and predictors of bone density among osteoporotic women in Mexico City. Calcif Tissue Int. 1996;59:89–94. doi: 10.1007/s002239900092. [DOI] [PubMed] [Google Scholar]
  • 38.Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Eng J Med. 1995;332:767–73. doi: 10.1056/NEJM199503233321202. [DOI] [PubMed] [Google Scholar]
  • 39.O'Neill TW, Silman AJ, Naves Diaz M, Cooper C, Kanis J, Felsenberg D. Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. Osteoporos Int. 1997;7:72–8. doi: 10.1007/BF01623464. [DOI] [PubMed] [Google Scholar]
  • 40.Streeten EA, Ryan KA, McBride DJ, Pollin TI, Shuldiner AR, Mitchell BD. The relationship between parity and bone mineral density in women characterized by a homogeneous lifestyle and hgh parity. J Clin Endocrinol Metab. 2005;90:4536–41. doi: 10.1210/jc.2004-1924. [DOI] [PubMed] [Google Scholar]
  • 41.Berehi H, Kolhoff N, Constable A, Nielsen SP. Multiparity and bone mass. Br J Obstet Gynaecol. 1996;103:818–21. doi: 10.1111/j.1471-0528.1996.tb09880.x. [DOI] [PubMed] [Google Scholar]
  • 42.Hillier TA, Rizzo JH, Pedula KL, Stone KL, Cauley JA, Bauer DC, Cummings SR. Nulliparity and fracture risk in older women: the study of osteoporotic fractures. J Bone Miner Res. 2003;18:893–9. doi: 10.1359/jbmr.2003.18.5.893. [DOI] [PubMed] [Google Scholar]
  • 43.Petersen HC, Jeune B, Vaupel JW, Christensen K. Reproduction life history and hip fractures. Ann Epidemiol. 2002;12:257–63. doi: 10.1016/s1047-2797(01)00275-7. [DOI] [PubMed] [Google Scholar]
  • 44.Parazzini F, Tavani A, Ricci E, La Vecchia C. Menstrual and reproductive factors and hip fractures in postmenopausal women. Maturitas. 1996;24:191–6. doi: 10.1016/s0378-5122(96)82009-3. [DOI] [PubMed] [Google Scholar]
  • 45.Holmberg-Marttila D, Leino A, Sievänen H. Bone turnover markers during lactation postpartum amenorrhea and resumption of menses. Osteoporos Int. 2003;14:103–9. doi: 10.1007/s00198-002-1320-0. [DOI] [PubMed] [Google Scholar]
  • 46.Sowers M, Eyre D, Hollis B, Randolph JF, Shapiro B, Jannaush ML, et al. Biochemical markers of bone turnover in lactating and nonlactating postpartum women. J Clin Endocrinol Metab. 1995;80:2210–6. doi: 10.1210/jcem.80.7.7608281. [DOI] [PubMed] [Google Scholar]
  • 47.Polatti F, Capuzzo E, Viazzo F, Colleoni R, Klersy C. Bone mineral changes during and after lactation. Obstet Gynecol. 1999;94:52–6. doi: 10.1016/s0029-7844(99)00236-7. [DOI] [PubMed] [Google Scholar]
  • 48.Holmberg-Marttila D, Sievänen H. Prevalence of bone mineral changes during postpartum amenorrhea and after resumption of menses. Am J Obstet Gynecol. 1999;180:537–8. doi: 10.1016/s0002-9378(99)70250-4. [DOI] [PubMed] [Google Scholar]
  • 49.Affinito P, Tommaselli GA, Di Carlo C, Guida F, Nappi C. Changes in bone mineral density and calcium metabolism in breastfeeding women: a one year follow-up study. J Clin Endocrinol Metab. 1996;81:2314–8. doi: 10.1210/jcem.81.6.8964870. [DOI] [PubMed] [Google Scholar]
  • 50.Laskey MA, Prentice A. Effect of pregnancy on recovery of lactational bone loss. Lancet. 1997;349:1518. doi: 10.1016/S0140-6736(05)62097-1. [DOI] [PubMed] [Google Scholar]
  • 51.Kalkwarf HJ, Specker BL. Bone mineral loss during lactation and recovery after weaning. Obstet Gynecol. 1995;86:26–32. doi: 10.1016/0029-7844(95)00083-4. [DOI] [PubMed] [Google Scholar]
  • 52.Feldblum PJ, Zhang J, Rich LE, Fortney JA, Talmage RV. Lactation history and bone mineral density among perimenopausal women. Epidemiology. 1992;3:527–31. doi: 10.1097/00001648-199211000-00012. [DOI] [PubMed] [Google Scholar]
  • 53.Hu JF, Zhao XH, Chen JS, Fitzpatrick J, Parpia B, Campbell TC. Bone density and lifestyle characteristics in premenopausal and postmenopausal Chinese women. Osteoporos Int. 1994;4:288–97. doi: 10.1007/BF01622185. [DOI] [PubMed] [Google Scholar]
  • 54.Dursun N, Akin S, Dursun E, Sade I, Korkusuz F. Influence of duration of total breast-feeding on bone mineral density in a Turkish population: does the priority of risk factors differe from society to society? . Osteoporos Int . 2006;17:651–5. doi: 10.1007/s00198-005-0029-2. [DOI] [PubMed] [Google Scholar]
  • 55.Gur A, Cevik R, Nas K, Sarac AJ, Ataoglu S, Karakoc M, et al. The influence of duration of breastfeeding on bone mass in postmenopausal women of different age groups. J Bone Miner Metab. 2003;21:234–41. doi: 10.1007/s00774-003-0415-9. [DOI] [PubMed] [Google Scholar]
  • 56.Jones G, Scott FS. A cross-sectional study of smoking and bone mineral density in premenopausal parous women: effect of body mass index, breast feeding and sports participation. J Bone Miner Res. 1999;14:1628–33. doi: 10.1359/jbmr.1999.14.9.1628. [DOI] [PubMed] [Google Scholar]
  • 57.Chowdhury S, Sarkar NR, Roy SK. Impact of lactational performance on bone mineral density in marginally-nourished women. J Health Popul Nutr. 2002;20:26–30. [PubMed] [Google Scholar]
  • 58.Khoo CC, Woo J, Leung PC, Kwok A, Kwok T. Determinants of bone mineral density in older postmenopausal Chinese women. Climacteric. 2011;14:378–83. doi: 10.3109/13697137.2010.548566. [DOI] [PubMed] [Google Scholar]
  • 59.Rojano-Mejía D, Aguilar-Madrid G, López-Medina G, Cortes-Espinosa L, Hernández-Chiu MC, Canto-Cetina T, et al. Risk factors and impact on bone mineral density in postmenopausal Mexican mestizo women. Menopause. 2011;18:302–6. doi: 10.1097/gme.0b013e3181f2d3fb. [DOI] [PubMed] [Google Scholar]
  • 60.Carranza-Lira S, Mera JP. Influence of number ofpregnancies and total breast-feeding time on bone mineral density. Int J Fertil Womens Med. 2002;47:169–71. [PubMed] [Google Scholar]
  • 61.Kojima N, Douchi T, Kosha S, Nagata Y. Cross-sectional study of the effects of parturition and lactation on bone mineral density later in life. Maturitas. 2002;41:203–9. doi: 10.1016/s0378-5122(01)00296-1. [DOI] [PubMed] [Google Scholar]
  • 62.Lenora J, Lekamwasam S, Karlsson MK. Effects of multiparity and prolonged breast-feeding on maternal bone mineral density: a community-based cross-sectional study. BMC Womens Health. 2009;9:19. doi: 10.1186/1472-6874-9-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.More C, Bettembuk P, Bhattoa HP, Balogh A. The effects of pregnancy and lactation on bone mineral density. Osteoporos Int. 2001;12:732–7. doi: 10.1007/s001980170048. [DOI] [PubMed] [Google Scholar]
  • 64.Shilbayeh S. Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cress-sectional study. Osteoporos Int. 2003;14:929–40. doi: 10.1007/s00198-003-1458-4. [DOI] [PubMed] [Google Scholar]
  • 65.Aksakal O, Aytan H, Cavkaytar S, et al. Effect of lactation on bone mineral density later in life in Turkish women. Turk J Med Sci. 2008;38:329–33. [Google Scholar]
  • 66.Wiklund PK, Xu L, Wang Q, Mikkola T, Lyytikäinen A, Vőlgyi E, et al. Lactation is associated with greater maternal bone size and bone strength later in life. Osteoporos Int. 2012;23:1939–45. doi: 10.1007/s00198-011-1790-z. [DOI] [PubMed] [Google Scholar]
  • 67.Yazici S, Korkmaz U, Erkan M, Korkmaz N, Baki AE, Alçelik A, et al. The effect of breast-feeding duration on bone mineral density in postmenopausal Turkish women: a population-based study. Arch Med Sci. 2011;3:486–92. doi: 10.5114/aoms.2011.23416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Berning B, van Kuijk C, Schütte HE, Kuiper JW, Drogendijk AC, Fauser BCJM. Determinants of lumbar bone mineral density in normal weight non-smoking women soon after menopause. A study using clinical data and quantitative computed tomography. Bone Miner. 1993;21:129–39. doi: 10.1016/s0169-6009(08)80015-3. [DOI] [PubMed] [Google Scholar]
  • 69.Schnatz PF, Marakovits KA, O´Sullivan DM. Assessment of postmenopausal women and significant risk factors for osteoporosis. Obstet Gynecol Surv. 2010;65:591–6. doi: 10.1097/OGX.0b013e3181fc6d30. [DOI] [PubMed] [Google Scholar]
  • 70.Cure-Cure C, Cure-Ramierz P, Teran E, Lopez-Jaramillo P. Bone mass peak in multiparity and reduced risk of bone fractures in menopause. Int J Gynecol Obstet. 2002;76:285–91. doi: 10.1016/s0020-7292(01)00583-5. [DOI] [PubMed] [Google Scholar]
  • 71.Lissner L, Bengtsson C, Hansson T. Bone mineral content in relation to lactation history in pre and postmenopausal women. Calcif Tissue Int. 1991;48:319–25. doi: 10.1007/BF02556151. [DOI] [PubMed] [Google Scholar]
  • 72.Henderson PH 3rd, Sowers M, Kutzko KE, Jannausch ML. Bone mineral density in grand multiparous women with extended lactation. Am J Obstet Gynecol. 2000;182:1371–7. doi: 10.1067/mob.2000.107468. [DOI] [PubMed] [Google Scholar]
  • 73.Grainge MJ, Coupland CA, Cliffe SJ, Chilvers CE, Hosking DJ. Reproductive menstrual and menopausal factors: which are associated with bone mineral density in early postmenopausal women. Osteoporos Int. 2001;12:777–87. doi: 10.1007/s001980170055. [DOI] [PubMed] [Google Scholar]
  • 74.Paton LM, Alexander JL, Nowson CA, Margerison C, Frame MG, Kaymakci B, et al. Pregnancy and lactation have no long-term deleterious effect on measures of bone mineral in healthy women: a twin study. Am J Clin Nutr. 2003;77:707–14. doi: 10.1093/ajcn/77.3.707. [DOI] [PubMed] [Google Scholar]
  • 75.Kojima N, Douchi T, Kosha S, Nagata Y. Cross-sectional study of the effects of parturition and lactation on bone mineral density later in life. Maturitas. 2002;41:203–9. doi: 10.1016/s0378-5122(01)00296-1. [DOI] [PubMed] [Google Scholar]
  • 76.Zhang YY, Liu PY, Deng HW. The impact of reproductive and menstrual history on bone mineral density in Chinese women. J Clin Densit. 2003;6:289–96. doi: 10.1385/jcd:6:3:289. [DOI] [PubMed] [Google Scholar]
  • 77.Karlsson C, Obrant KJ, Karlsson M. Pregnancy and lactation confer reversible bone loss in humans. Osteoporos Int. 2001;12:828–34. doi: 10.1007/s001980170033. [DOI] [PubMed] [Google Scholar]
  • 78.Hill DD, Cauley JA, Bunker CH, et al. Correlates of bone mineral density among postmenopausal women of African Caribbean ancestry: Tobago womens health study. Bone. 2008;43:156–61. doi: 10.1016/j.bone.2008.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Chantry CJ, Auinger P, Byrd RS. Lactation among adolescent mothers and subsequent bone mineral density. Arch Pediatr Adolesc Med. 2004;158:650–6. doi: 10.1001/archpedi.158.7.650. [DOI] [PubMed] [Google Scholar]
  • 80.Hadji P, Ziller V, Kalder M, Gottschalk M, Hellmeyer L, Hars O, et al. Influence of pregnancy and breast-feeding on quantitative ultrasonometry of bone in postmenopausal women. Climacteric. 2002;5:277–85. [PubMed] [Google Scholar]
  • 81.Paganini-Hill A, Chao A, Ross RK, Henderson BE. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology. 1991;2:16–25. doi: 10.1097/00001648-199101000-00004. [DOI] [PubMed] [Google Scholar]
  • 82.Cumming RG, Nevitt MC, Cummings SR. Epidemiology of hip fractures. Epidemiol Rev. 1997;19:244–57. doi: 10.1093/oxfordjournals.epirev.a017956. [DOI] [PubMed] [Google Scholar]
  • 83.Kauppi M, Heliővaara M, mImpivaara O, Knekt P, Jula A. Parity and risk of hip fracture in postmenopausal women. Osteoporos Int. 2011;22:1765–71. doi: 10.1007/s00198-010-1392-1. [DOI] [PubMed] [Google Scholar]
  • 84.Taylor BC, Schreiner PJ, Stone KL, Fink HA, Cummings SR, Nevitt MC, et al. Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc. 2004;52:1479–86. doi: 10.1111/j.1532-5415.2004.52410.x. [DOI] [PubMed] [Google Scholar]
  • 85.Paganini-Hill A, Atchison KA, Gombein JA, Nattiv A, Service SK, White SC. Menstrual and reproductive factors and fracture risk: the Leisure World Cohort Study. J Women Health. 2005;14:808–19. doi: 10.1089/jwh.2005.14.808. [DOI] [PubMed] [Google Scholar]
  • 86.Michaëlsson K, Baron JA, Farahmand BY, Ljunghall S. Influence of parity and lactation on hip fracture risk. Am J Epidemiol. 2001;153:1166–72. doi: 10.1093/aje/153.12.1166. [DOI] [PubMed] [Google Scholar]
  • 87.Specker B, Binkley T. High parity is associated with increased bone size and strength. Osteoporos Int. 2005;16:1969–74. doi: 10.1007/s00198-005-1978-1. [DOI] [PubMed] [Google Scholar]
  • 88.Huo D, Lauderdale DS, Li L. Influence of reproductive factors on hip fracture risk in Chinese women. Osteoporos Int. 2003;14:694–700. doi: 10.1007/s00198-003-1429-9. [DOI] [PubMed] [Google Scholar]
  • 89.Cumming RG, Klineberg R. Breastfeeding and other reproductive factors and the risk of hip fracture in elderly women. Int J Epidemiol. 1993;22:684–91. doi: 10.1093/ije/22.4.684. [DOI] [PubMed] [Google Scholar]
  • 90.Kreiger N, Kelsey JL, Holford TR, O'Connor T. An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol. 1982;116:141–8. doi: 10.1093/oxfordjournals.aje.a113388. [DOI] [PubMed] [Google Scholar]
  • 91.Boonyaratavej N, Suriyawongpaisal P, Takkinsatien A, Wanvarie S, Rajatanavin R, Apiyasawat P. Physical activity and risk factors for hip fractures in Thai women. Osteoporos Int. 2001;12:244–8. doi: 10.1007/s001980170136. [DOI] [PubMed] [Google Scholar]
  • 92.Naves M, Diaz-López JB, Ġomez C, Rodriguez-Rebollar A, Cannata-Andia JB. Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50. Osteoporos Int. 2005;16:2013–7. doi: 10.1007/s00198-005-1983-4. [DOI] [PubMed] [Google Scholar]
  • 93.Mallmin H, Ljunghall S, Persson I, Bergstrom R. Risk factors for fractures of the distal forearm: a population-based case-control study. Osteoporos Int. 1994;4:298–304. doi: 10.1007/BF01622186. [DOI] [PubMed] [Google Scholar]
  • 94.More C, Bhattoa HP, Bettembuk P, Balogh A. The effects of pregnancy and lactation on hormonal status and biochemical markers of bone turnover. Eur J Obstet GYnecol Reprod Biol. 2003;106:209–13. doi: 10.1016/s0301-2115(02)00237-3. [DOI] [PubMed] [Google Scholar]
  • 95.Bezerra FF, Laboissière FP, King JC, Donangelo CM. Pregnancy and lactation affect markers of calcium and bone metabolism differently in adolescent and adult women with low calcium intakes. J Nutr. 2002;132:2183–7. doi: 10.1093/jn/132.8.2183. [DOI] [PubMed] [Google Scholar]
  • 96.Uemura H, Yasui T, Kiyokawa M, Kuwahara A, Ikawa H, Matsuzaki T, et al. Serum osteoprotegerin/ osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. J Endocrinol. 2002;174:353–9. doi: 10.1677/joe.0.1740353. [DOI] [PubMed] [Google Scholar]
  • 97.Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblast cells. Endocrinology. 1999;140:4367–70. doi: 10.1210/endo.140.9.7131. [DOI] [PubMed] [Google Scholar]
  • 98.Yano K, Shibata O, Mizuno A, Kobayashi F, HIgashio K, Morinaga T, et al. Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF): possible role of OPG/OCIF in the prevention of osteoporosis in pregnancy. Biochem Biophys Res Common. 2001;288:217–24. doi: 10.1006/bbrc.2001.5745. [DOI] [PubMed] [Google Scholar]
  • 99.Naylor KE, Rogers A, Fraser RB, Hall V, Eastell R, Blumsohn A. Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. J Clin Endocrinol Metab. 2003;88:5361–5. doi: 10.1210/jc.2003-030486. [DOI] [PubMed] [Google Scholar]
  • 100.Vidal K, van den Broek P, Lorget F, Donnet-Hughes A. Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development. Pediatr Res. 2004;55:1001–8. doi: 10.1203/01.pdr.0000127014.22068.15. [DOI] [PubMed] [Google Scholar]
  • 101.Cross NA, Hillman LS, Allen S, Krause GF, Vieira NE. Calcium homeostasis and bone metabolism during pregnancy lactation and post-weaning: a longitudinal study. Am J Clin Nutr. 1995;61:514–23. doi: 10.1093/ajcn/61.3.514. [DOI] [PubMed] [Google Scholar]
  • 102.Cross NA, Hillman LS, Allen SH, Krause GF. Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium. J Bone Miner Res. 1995;10:1312–20. doi: 10.1002/jbmr.5650100907. [DOI] [PubMed] [Google Scholar]
  • 103.Kovacs CS, Chik CL. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium phosphate parathyroid hormone (PTH), and PTH-related peptide levels. J Clin Endocrinol Metab. 1995;80:3036–42. doi: 10.1210/jcem.80.10.7559893. [DOI] [PubMed] [Google Scholar]
  • 104.Gallacher SJ, Fraser WD, Owens OJ. Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur J Endocrinol. 1994;131:369–74. doi: 10.1530/eje.0.1310369. [DOI] [PubMed] [Google Scholar]
  • 105.Chan SM, Nelson EAS, Leung SSF, Cheng JCY. Bone mineral density and calcium metabolism of Hong Kong Chinese postpartum women—a 1-y longitudinal study. Eur J Clin Nutr. 2005;59:868–76. doi: 10.1038/sj.ejcn.1602148. [DOI] [PubMed] [Google Scholar]
  • 106.Carneiro RM, Prebehalla L, Tedesco MB, SEreika SM, Hugo M, Hollis BW, et al. Lactation and bone turnover: a conundrum of marked bone loss in the setting of coupled bone turnover. J Clin Endocrinol Metab. 2010;95:1767–76. doi: 10.1210/jc.2009-1518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Gruber HE, Gutteidge DH, Baylink DJ. Osteoporosis associated with pregnancy and lactation: bone biopsy and skeletal features in three patients. Metab Bone Dis Rel Res. 1984;5:159–65. doi: 10.1016/0221-8747(84)90023-7. [DOI] [PubMed] [Google Scholar]
  • 108.Smith R, Stevenson JC, Winearls CG, Woods CG, Wordsworth BP. Osteoporosis of pregnancy. Lancet. 1985;1:1178–80. doi: 10.1016/s0140-6736(85)92861-2. [DOI] [PubMed] [Google Scholar]
  • 109.Prentice A. Calcium intakes and bone densities of lactating women and breast-fed infants in the Gambia. Adv Exp Med Biol. 1994;352:243–55. doi: 10.1007/978-1-4899-2575-6_22. [DOI] [PubMed] [Google Scholar]
  • 110.Kung AW, Luk KD, Chu LW, Chiu PK. Age-related osteoporosis in Chinese: an evaluation of the response of intestinal calcium absorption and calcitropic hormones to dietary calcium deprivation. Am J Clin Nutr. 1998;68:1291–7. doi: 10.1093/ajcn/68.6.1291. [DOI] [PubMed] [Google Scholar]
  • 111.Woo J, Meung SSF, Ho SC, Chan SM. Is there a typical Chinese diet and what are the health implications? Ecol Food Nutr . 1999;38:491–503. [Google Scholar]
  • 112.Lamke B, Brundin J, Moberg P. Changes of bone mineral content during pregnancy and lactation. Acta Obstet Gynecol Scand. 1977;56:217–219. doi: 10.3109/00016347709162123. [DOI] [PubMed] [Google Scholar]
  • 113.Sowers MF, Crutchfield M, Jannausch M, Updike S, Corton G. A prospective evaluation of bone and mineral change in pregnancy. Obstet Gynecol. 1991;77:841–5. [PubMed] [Google Scholar]
  • 114.Kent GN, Rice RI, Gutteridge DH, Smith M, Allen JR, Bhagat CI, et al. Effect of pregnancy and lactation on maternal bone mass and calcium metabolism. Osteoporos Int. 1993;3:44–7. doi: 10.1007/BF01621861. [DOI] [PubMed] [Google Scholar]
  • 115.Naylor KE, Iqbal P, Fledelius RB, Fraser RB, Eastell R. The effect of pregnancy on bone mineral density and bone turnover. Am J Bone Miner Res. 2000;15:129–37. doi: 10.1359/jbmr.2000.15.1.129. [DOI] [PubMed] [Google Scholar]
  • 116.Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD. A detailed assessment of alterations in bone turnover, calcium homeostasis and bone density in normal pregnancy. J Bone Miner Res. 2000;15:557–63. doi: 10.1359/jbmr.2000.15.3.557. [DOI] [PubMed] [Google Scholar]
  • 117.Tsurusaki K, Ito M, Hayashi K. Differential effects of menopause and metabolic disease on trabecular and cortical bone assessed by peripheral quantitative computed tomography (QCT) Br J Radiol. 2000;73:14–22. doi: 10.1259/bjr.73.865.10721315. [DOI] [PubMed] [Google Scholar]
  • 118.Buchanan JR, Myers C, Lloyd T, Greer RB. Early vertebral trabecular bone loss in normal premenopausal women. J Bone Miner Res. 1988;3:583–7. doi: 10.1002/jbmr.5650030515. [DOI] [PubMed] [Google Scholar]
  • 119.Kang C, Speller R. Comparison of ultrasound and dual energy X-ray absorptiometry measurement in the calcaneus. Br J Radiol. 1998;71:861–7. doi: 10.1259/bjr.71.848.9828799. [DOI] [PubMed] [Google Scholar]
  • 120.Hadji P, Hars O, Wüster C, Bock K, Alberts US, Bohnet HG, et al. Stiffness index identifies patients with osteoporotic fractures better than ultrasound velocity or attenuation alone. Maturitas. 1999;31:221–6. doi: 10.1016/s0378-5122(99)00003-1. [DOI] [PubMed] [Google Scholar]
  • 121.Della Martina M, Biasioli A, Vascotto L, Rinuncini D, Adorati Menegato A, Liva S, et al. Bone ultrasonometry measurements during pregnancy. Arch Gynecol Obstet. 2010;281:401–7. doi: 10.1007/s00404-009-1133-x. [DOI] [PubMed] [Google Scholar]
  • 122.Young D, Hopper JL, Nowson CA, Green RM, Sherwin AJ, Kaymakci B, et al. Determinants of bone mass in 11-26 years old females: a co-twin study. J Bone Miner Res. 1995;10:558–67. doi: 10.1002/jbmr.5650100408. [DOI] [PubMed] [Google Scholar]
  • 123.Lovejoy JC. The influence of sex hormones on obesity across the female life span. J Womens Health. 1998;7:1247–56. doi: 10.1089/jwh.1998.7.1247. [DOI] [PubMed] [Google Scholar]
  • 124.Weaver CM, Peacock M, Martin BR, Plawecki KL, McCabe GP. Calcium retention estimated from indicators of skeletal status in adolescent girls and young women. Am J Clin Nutr. 1996;64:67–70. doi: 10.1093/ajcn/64.1.67. [DOI] [PubMed] [Google Scholar]
  • 125.Michaëlsson K, Bergstrőm R, Holmberg L, Mallmin H, Wolk A, Ljunghall S. Calcium intake among women aged 40-76 in Sweden. J Epidemiol Community Health. 1996;50:577–8. doi: 10.1136/jech.50.5.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Kalkwarf HJ, Specker BL, Bianchi DC, Ranz J, Ho M. The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med. 1997;337:523–8. doi: 10.1056/NEJM199708213370803. [DOI] [PubMed] [Google Scholar]
  • 127.Sowers M, Zhang D, Hollis BW, Shapiro B, Janney CA, Crutchfield M, et al. Role of calciotrophic hormones in calcium mobilization of lactation. Am J Clin Nutr. 1998;67:284–91. doi: 10.1093/ajcn/67.2.284. [DOI] [PubMed] [Google Scholar]
  • 128.Prentice A, Jarjou LM, Cole TJ, Stirling DM, Dibba B, Fairweather-Tait S. Calcium requirements of lactating Gambian mothers: effects of a calcium supplement on breast-milk calcium concentration maternal bone mineral content and urinary calcium excretion. Am J Clin Nutr. 1995;62:58–67. doi: 10.1093/ajcn/62.1.58. [DOI] [PubMed] [Google Scholar]
  • 129.Lopez JM, Gonzales G, Reyes V, Campino C, Díaz S. Bone turnover and density in healthy women during breastfeeding and after weaning. Osteoporos Int. 1996;6:153–9. doi: 10.1007/BF01623940. [DOI] [PubMed] [Google Scholar]
  • 130.Miller SC, Bowman BM. Rapid improvements in cortical bone dynamics and structure after lactation in established breeder rats. Anat Rec A Discov Mol Cell Evol Biol. 2004;276:143–9. doi: 10.1002/ar.a.10138. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Family & Reproductive Health are provided here courtesy of Tehran University of Medical Sciences

RESOURCES